The major components of human submandibular-sublingual saliva (HSMSL) are mucins, amylases, cystatins, prolinerich proteins and statherin. Structure-function studies of these molecules have been hampered by the small amounts of purified materials that can be isolated from human secretions. The present study describes an integrated purification protocol for the large-scale preparation of many of these molecules. To dissociate partially heterotypic complexes among salivary molecules, HSMSL was initially fractionated into four pools by gel filtration with 6 M-guanidine hydrochloride. Subsequent fractionation of these four pools by gel-filtration and ion-exchange chromatography resulted in the purification of high-and low-Mr mucins, neutral and acidic cystatins, acidic and basic proline-rich proteins and statherin. Many variants or isoforms of these salivary molecules have been identified and biochemically characterized. Biochemical studies indicated that the low-Mr mucin exists as two isoforms which vary in their sialic acid to fucose ratios. Three isoforms of acidic cystatin S were characterized which differ in their phosphate content. Two isoforms of a basic proline-rich peptide were identified; the smaller peptide was a truncated form missing the first seven amino acids.
INTRODUCTION
It is well established that human submandibular-sublingual saliva (HSMSL), which can comprise at least 50 % of the total salivary secretions, contains several groups of families of proteins and glycoproteins which mediate various functions in the oral cavity. These include mucins, cystatins, amylases, proline-rich proteins (PRPs) and statherin. These families occur in saliva as multiple isoforms which originate from transcriptional, translational and/or post-translational modifications Minaguchi & Bennick, 1989) . They participate in a wide array of biological functions including mineralization processes (Moreno et al., 1982; Shomers et al., 1982c; Bennick et al., 1983) , tissue coating (Kousvelari et al., 1980; Bennick et al., 1983; Fisher et al., 1987; Al-Hashimi & Levine, 1989) , lubrication (Hatton et al., 1985; Levine et al., 1987; Aguirre et al., 1989a,b; Gans et al., 1990) , microbial attachment (Levine et al., 1978; Stinson et al., 1982; Murray et al., 1982 Murray et al., , 1986 Douglas, 1983; Gibbons et al., 1983; Morris & McBride, 1984; Gibbons & Hay, 1988; Scannapieco et al., 1989 Scannapieco et al., , 1990 , antimicrobial activity (Mellersh et al., 1979; Obenauf et al., 1986) and digestion (Cohen & Levine, 1989) . Understanding the functional relationships among individual variants or isoforms requires a knowledge of their biochemical structure which, in turn, is dependent on having sufficient amounts of purified materials for study. Investigators in salivary research have by and large focused their attention on purification of only those salivary proteins that are of particular interest to them. Consequently, there is no generalized protocol available for the efficient preparation of many of the different salivary molecules from intact or native secretions at the same time. In the present study, an integrated protocol has been developed, based on separate procedures developed by several investigators, which permits the efficient purification of the major components of HSMSL saliva. These include high-and low-Mr mucins, representative acidic and basic PRPs, neutral and acidic cystatins and statherin. Data are presented that demonstrate the existence of multiple isoforms of these molecules and the biochemical differences of these variants.
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Chromatography was carried out at room temperature using buffer 1 at a flow rate of 3-5 ml/h. Pools A-D were then screened by SDS/PAGE on 10 % (w/v) gels. Immunoblotting identified the salivary components shown. Mr markers include: rabbit muscle phosphorylase b (94000), BSA (67000), ovalbumin (43000), bovine erythrocyte carbonic anhydrase (30000) and soya-bean trypsin inhibitor (20100).
stone, Kent, U.K. Isolation of salivary components HSMSL from a 30-year-old healthy female donor was collected and processed as previously described (Shomers et al., 1982a) . For all subsequent chromatography steps, pooled fractions were dialysed extensively against cold distilled water using Spectra/ Por 3 tubing (Spectrum Medical Industries Inc., Los Angeles, CA, U.S.A.) and then freeze-dried. The proteins and glycoproteins of HSMSL were initially fractionated according to size by gel filtration on Sephadex G-200 using buffer with guanidine hydrochloride. Four pools (A-D) were obtained which comprised about 18, 6, 60 and 16 % respectively of the total materials (dry weight) applied to the column (Fig. 1) . Several columns were run in order to accumulate enough of these pools for the purification of the components described below. These pools were then screened by SDS/PAGE or by immunoblotting (Fig. 1) For the purification of MG2, freeze-dried pool A2 (Fig. 2a ) was subjected to reductive methylation as described by Jentoft & Dearborn (1979) and Prakobphol et al. (1982) with some modifications. Pool A2 was solubilized at a concentration of 20 mg/ml in buffer 2 which contained 6 M-urea. On occasion, the samples were not completely soluble in this buffer and a turbid solution resulted. This problem was overcome by the addition of small amounts of urea with gentle stirring. The clear solution was incubated at 37°C with [14C]formaldehyde (10-fold molar excess over the lysine content of the sample) in the presence of 100 mmsodium cyanoborohydride. After 1-2 h, unlabelled formaldehyde (4 x the amount of [14C]formaldehyde) was added and the mixture was further incubated for 24 h at 37 'C. The reaction mixture was fractionated (and desalted) on Sephacryl S-300 using buffer 3. MG2-containing fractions (RM MG2) were localized by SDS/PAGE/fluorography using 14C-labelled MG2 as a marker and then pooled accordingly (Fig. 2b) .
A second modification of the MG2 purification protocol was introduced which involved the reduction and alkylation of RM MG2 followed by chromatography on Sephacryl S-300 with 6 Murea. For reduction and alkylation, 50 mg of RM MG2-containing materials were solubilized at a concentration of 10 mg/ml in 0.1 M-Tris/HCl with 2 % disodium EDTA and 8 M-urea, pH 8.5, and reduced for 16 h with a 150-fold molar excess of dithiothreitol (DTT) (over half-cysteine content of the sample). The reduced sample was then alkylated for 1-2 h with a 2-fold molar excess (over the DTT content) of iodoacetic acid. Before addition, the pH of iodoacetic acid was adjusted to 8.0-8.5 with 1 M-NaOH. Both the reduction and alkylation procedures were carried out in the dark under N2. (a) Gel filtration of pool A (150 mg in 5-6 ml of buffer 1) on a column (1.6 cm x 100 cm) of Sepharose CL-2B. Chromatography was carried out at room temperature using buffer 1 at 4-6 ml/h. (b) Gel filtration of "C-labelled reduced and methylated pool A2 (100 mg in 5 ml of buffer 2) on a column (1.5 cm x 160 cm) of Sephacryl S-300. Chromatography was carried out at room temperature using buffer 3 at a flow rate of 3-5 ml/h. The sample (40 mg) was solubilized at a concentration of 2-3 mg/ml in equilibrating buffer (0.005 M-sodium phosphate, pH 8.0). After elution with 2 bed vol. of equilibrating buffer, the column was eluted with 100 ml each of a linear gradient from 0.005 M-and 0.15 M-sodium phosphate, pH 8.0. Next, the column was eluted with 100 ml of 0.15 M-sodium phosphate, pH 8.0, followed by 100 ml of 0.15 M-sodium phosphate, pH 8.0, containing 1 M-NaCl. Chromatography was performed at 6°C at a flow rate of 10-12 ml/h. Fractions were monitored by liquid-scintillation spectroscopy.
SDS/PAGE/fluorography (lanes 1-3) and anionic-PAGE/fluorography (lanes 4-6) of MG2a (lanes 1 and 4), MG2b (lanes 2 and 5) and acidic peptides (lanes 3 and 6). All experiments used 7.5 % gels. The column (2.5 cm x 50 cm) was eluted initially with 500 ml of buffer 4. Bound materials were eluted using a linear gradient consisting of 500 ml each of buffer 4 and buffer 5. After being washed with another 500 ml of buffer 5, additional materials were eluted with a linear salt gradient consisting of 500 ml of buffer 5 and 500 ml of buffer 6. Fractions were collected at 6°C at a flow rate of 50-60 ml/h. (b) DEAE-cellulose DE-52 chromatography of pool C4 (200 mg in 8-10 ml of buffer 5). The column (1.5 cm x 120 cm) was eluted using a linear gradient consisting of 11 each of buffer 5 and buffer 7. Fractions were collected at 6°C at a flow rate of 15-20 ml/h.
HSMSL on Sephadex G-200 resulted in the localization of amylase in pool A instead of pool C. Therefore gel filtration of pool C in the presence of high salt was no longer needed to separate amylase from neutral cystatin (Al-Hashimi et al., 1988) . Pool C was subjected to anion-exchange chromatography on DEAE-cellulose . Fractions (CI-C4) were pooled as indicated in Fig. 4 (a). Anionic-PAGE followed by immunoblotting with rabbit anti-(human neutral cystatin) localized neutral cystatin SA-I in pool C2, three acidic cystatins (designated C4a-4c) in pool C4 and a small amount of cystatin in pool C3. Cystatins C4a-4c were then separated by chromatography on a longer column of DEAE-cellulose using a shallow linear gradient, and fractions were pooled as shown in Fig. 4 (b). Final purification of acidic cystatins was attained by f.p.l.c. using an anionexchange Mono Q HR5/5 column (Fig. Sa) . The thiol-blocking proteinase inhibitory activity of cystatins ( (Fig. 7a) . Examination of these pools by anionic-PAGE revealed an incomplete separation of components (Fig. 7b) . Nevertheless, pool C3i (lane I 1) was more homogeneous than the others. Minor contaminants in pool C3i were removed by f.p.l.c. using a Mono Q HR5/5 column (Fig. 7c) .
Basic proline-rich peptides and statherin. Amino acid analysis of the low-Mr materials in pool D revealed that proline and tyrosine comprised approx. 26% and 10% of the total amino acids, suggesting the presence of proline-rich peptides and the tyrosine-rich peptide or statherin. Consequently, pool D was fractionated on DEAE-cellulose into two pools, Dl and D2 (Fig.   8a ). Amino acid analysis indicated that pool Dl, which did not bind to DEAE-cellulose, contained a high content of proline and glycine and therefore represented basic proline-rich peptides. (Warren, 1959) .
The tryptophan content of salivary proteins was determined after hydrolysis with 200 u1 of 4.0 M-methanesulphonic acid containing 0.2% tryptamine, for 24 h at 115 'C. The hydrolysate was partially neutralized with 3.5 M-NaOH before amino acid analysis (Simpson et al., 1976 (Loomis et al., 1987) .
For immunoblotting (Towbin et al., 1979; Burnette, 1981) incubated with an appropriate dilution of antiserum at room temperature for 1 h with gentle agitation, and then washed three times for 10 min each with 0.1 % BSA in TBS. Next, the membrane was incubated with HRP-conjugated goat anti-rabbit IgG or rabbit anti-goat IgG for I h followed by washing for 10 min three times with 0.1 % BSA. Antigens were revealed with HRP colour-development reagent (0.5 mg of 4-chloronaphthol/ ml in 50 mM-TBS and 0.03 % hydrogen peroxide).
Antisera
Rabbit anti-(human neutral cystatin) was prepared in New Zealand White rabbits by the immunization protocol of Shomers et al. (1982a) . Rabbit antibody against partially deglycosylated MG2 was prepared as described by Cohen et al. (1991) Phosphate analyses 0.5
The phosphate content of salivary proteins was determined colorimetrically by the procedure of Chen et al. (1956) and/or by n.m.r. spectroscopy as described by Vogel & Bridger (1982) . For 0.4 n.m.r., standard curves were generated from solutions The location of phosphoserine residues in the N-terminal region of acidic cystatins was assessed after the conversion of phosphoserine into S-ethylcysteine (Meyer et al., 1987) . 10 ml of buffer 4). The column (2.5 cm x 50 cm) was subjected to the same gradients that were used for pool C (Fig. 4a) Loomis et al., 1987 respectively). We employed several approaches to dissociate these complexes including urea and reductive methylation. However, these procedures usually required several time-consuming recycling steps through various gel matrices to ensure mucin purification. This resulted in lower yields and did not completely resolve the poor solubility properties of these molecules. Consequently, we have modified our mucin-purification protocols. The first modification involves the use of guanidine hydrochloride (buffer 1) instead of urea in the initial gel-filtration steps. The guanidine hydrochloride greatly enhanced the solubility of freeze-dried HSMSL (see above) and crude mucin-containing fractions. As shown in Fig. 2(a) , gel filtration of pool A on Sepharose CL-2B separated MG1 (pool Al) from MG2 (pool A2). MG1 which was then purified from pool Al using guanidine-containing buffers (results not shown) was identical in composition with that obtained using urea-containing buffers (Loomis et al., 1987) . Previously for MG2 purification, reductive methylation alone was used to dissociate the smaller peptides whereas repeated recycling through Sephadex G-200 with 6 M-urea or immunoaffinity columns of anti-sIgA was used to dissociate the sIgA . These recycling steps greatly diminished the yields of MG2. To maximize the dissociation of sIgA from MG2 and increase the yields of this mucin, reductive methylation was followed by a reduction and alkylation step and each was accompanied by gel filtration under dissociating conditions. Finally, MG2-enriched materials (RM/RA MG2, Fig. 2c ) were subjected to ion-exchange chromatography on DEAE-Sepharose CL-6B (Fig. 3) . A first pool was obtained during gradient elution at approx. 0.025 M-sodium phosphate, pH 8.0, a second pool was eluted with 0.15 M-sodium phosphate, and a third pool was eluted with 1 M-NaCl. As shown by SDS/PAGE/fluorography, the first two pools contained predominantly materials with an RF comparable with MG2 and represent two isoforms designated MG2a and MG2b respectively (Fig. 3) . The third pool contained mostly low-Mr components and only trace amounts of MG2 (Fig. 3) . Anionic-PAGE/fluorography of MG2a and MG2b also indicated that these preparations were free of acidic peptides (Fig. 3 ). MG2b had a higher sialic acid content than MG2a (Table 1) and migrated faster than MG2a during both SDS/PAGE and anionic-PAGE. The existence of two isoforms of MG2 which differ in their charge properties explains the charge heterogeneity previously reported for this mucin . The amino acid compositions of MG2-containing fractions obtained during various steps of purification are compared with that of MG2a and MG2b (Table 2 ). The content of acidic amino acids (Asx and Glx) decreased as purity of the MG2 preparations increased. These two residues comprised the major amino acids present in the acidic peptide fractions. In general, the amino acid compositions of MG2a and MG2b were similar to each other and comparable with that reported previously for MG2 , suggesting that the two species may have identical peptide moieties. Characteristically, purified MG2a and MG2b preparations have a high content of proline and alanine and very low amounts of glycine. Major differences between MG2a and MG2b were found in their carbohydrate content where MG2a had a lower content of sialic acid and a higher content of fucose than MG2b (Table 1 ). The chemical composition of MG2a and MG2b does not appear to vary among different individuals since the MG2 isoforms prepared from five different subjects had identical elution profiles on DEAE-Sepharose CL-6B and comparable amino acid profiles.
The effects of reductive methylation and/or reduction and alkylation on the purity of MG2a and MG2b were determined by eliminating each of these steps during the purification protocol. The amino acid compositions of mucins prepared by eliminating the reductive methylation step were comparable with those prepared as outlined above. However, for ease of monitoring the column eluates, radiolabelling by reductive methylation may be desirable. In contrast, mucins that had not undergone reduction and alkylation had a lower content of Ser + Thr and Pro and a higher content of Gly, indicating that this step is necessary to dissociate and/or prevent co-elution of acidic peptides with mucins from DEAE-Sepharose CL-6B.
Cystatins
Earlier studies have shown that human saliva contains at least three genetically distinguishable forms of cystatins, namely cystatin S (HPS-12), cystatin SA and cystatin SN (SA-I) (Isemura et al., 1984a (Isemura et al., ,b, 1987 Hawke et al., 1987; Al-Hashimi et al., 1988) . HSMSL contains at least seven cystatins (one neutral and six acidic isoforms) which have not undergone post-translational proteolytic processing (Shomers et al., 1982a; Al-Hashimi et al., 1988) . However, the acidic cystatins differ in their overall charge and in their degree of phosphorylation (Shomers et al., 1982b) .
The protocol for the isolation of neutral salivary cystatin, previously designated SA-I, has been modified slightly from that previously described by Al-Hashimi et al. (1988) . As before (AlHashimi et al., 1988) , final purification of the neutral cystatin from pool C2 was achieved by Mono Q anion-exchange chromatography (Fig. 5a) . N-terminal sequencing revealed a single tryptophan residue. Since cystatin SA-I (Al-Hashimi et al., 1988) has an identical amino acid composition and sequence with cystatin SN described by Saitoh et al. (1987 Saitoh et al. ( , 1988 and to eliminate confusion among nomenclatures from different laboratories, this neutral cystatin will be referred to as cystatin SN. T The three most acidic cystatins loca-lized in pool C4 were separated by sequential anion-exchange chromatography on 1991 (Fig. 2a) (Fig. 2b ) (Fig. 2c ) MG2a MG2b MG2* (Fig. 4 (Table 3 and Fig. 9 ). The neutral cystatin and acidic cystatin C4b contained less than 0.1 residue of hexosamines per molecule, indicating that they are not glycosylated.
Our previous studies suggested that differences in anionic mobility among the three acidic cystatins was probably due to varying levels of phosphorylation (Shomers et al., 1982b) . Alkaline phosphatase treatment of pool C4b and C4c followed by anionic-PAGE revealed that their relative mobilities were now equivalent to that of C4a suggesting that C4a is not phosphorylated (Fig. 5b) Trp-Ser-Pro-Lys-Glu-Glu-Asp-Arg-le-Ile-Pro-Gly-Gly-Ile-Tyr-AAsIna-Asp-Leu-Asn-Asp-GIu-Trp-Val-Gln-S:
Ser-Ser-Ser-Lys-Glu-Glu-Asn-Arg-Ile-Ile-Pro-Gly-Gly-Ile-Tyr-Asp-Ala-Asp-Leu-Asn-Asp-Glu-Trp-Val- Gln-26  30  35  SN: Arg-Ala-Leu-His-Phe-AIa-Ile-Ser-Glu-Tyr-S:
Arg-Ala-Leu-His-Phe-Ala-Ile-Ser-Glu-Tyr - Isemura et al. (1979). and two phosphate residues per molecule (Table 4 ). In addition, 31p n.m.r. spectroscopy indicated that no phosphate was present in cystatin SN whereas two residues of phosphate were found in purified statherin. Several studies have indicated that the consensus sequence for phosphorylation is Ser-X-Y where Y is an acidic residue, most notably glutamine (Henderson et al., 1981; Nisbet et al., 1981; Hamazume et al., 1985; Laber et al., 1989) .
With cystatin S, Ser-X-Glu occurs at positions 3-5 and 99-101 . Derivatization of C4b with ethanethiol and subsequent N-terminal sequencing indicated that the serine at position 3 was phosphorylated. If position 3 is phosphorylated, then the consensus sequence of Ser-X-Y could also be fulfilled for position 1. In fact, derivatized C4c could not be sequenced. In this context, Meyer et al. (1987) have indicated that an Nterminal phosphoserine is not transformed into S-ethylcysteine and instead pyruvate is formed resulting in a blocked N-terminus. Although these studies suggest that serine at position 1 in C4c might be phosphorylated, the location of the second phosphoserine remains to be definitely determined. Interestingly, Laber et al. (1989) have shown that the structural difference between two isoforms of chicken cystatin was due to the presence of phosphoserine at position 80. In contrast with other salivary phosphoproteins (e.g. PRP and statherin), where phosphoserine occurs in N-terminal domains, it is possible that certain isoforms of acidic salivary cystatins contain phosphoserine in C-terminal regions. Nevertheless, the three acidic cystatins represent variants or isoforms of cystatin S which differ in their degree of phosphorylation and can thus be designated cystatin S, SI and S2.
Information derived from sequence data Al-Hashimi et al., 1988) indicates that the ratios of Asp+ Glu and Asn + Gln in neutral cystatin SN and acidic cystatin S are 18/14 and 22/13 respectively. In addition, there are 18 residues of Lys + Arg in cystatin SN as compared with 14 residues of Lys + Arg in cystatin S. Collectively, these differences contribute to the acidic nature of cystatin S.
The purified cystatins described in this study (SN, S, S1 and S2) were all found to inhibit the proteolytic activity of papain with cystatin SN being the most active inhibitor (Fig. 6 ). This biological activity was not affected by previous exposure to 6 Mguanidine hydrochloride or 8 M-urea or by alkaline phosphatase treatment. In contrast, disruption of the disulphide bonds in cystatin SN and cystatin SI by reduction and alkylation abolished thiol-blocking proteinase inhibitory activity.
Acidic PRPs
Previous studies have identified acidic PRPs in human submandibular-sublingual secretions, but these have not been completely characterized (Bennick, 1977) . In the purification protocols described in this study, the acidic PRPs were localized in pool C3 by SDS/PAGE, anionic-PAGE and immunoblotting. This material was subsequently separated into 11 pools by anionexchange chromatography (Fig. 7a) . The high content of Pro, Gly and Glx in these pools indicated the presence of acidic PRPs. The PRP in pool C3i was purified to homogeneity by Mono Q anion-exchange chromatography (Fig. 7c) . This PRP displayed a single band on anionic-PAGE (Fig. 7b, lane 14) and had an amino acid composition comparable with PRP1 described by Hay et al. (1988) (Table 5) .
Several PRP-containing pools (primarily C3d and C3g), also Dlb: PCA-Arg-Gly-Pro-Arg-Gly-Pro-Tyr-Pro-Pro-Gly-Pro-Leu-Ala-Pro-Pro-Gln-Pro-Phe-Gly-Pro-Gly-Phe-Val-ProDla: Tyr-Pro-Pro-Gly-Pro-Leu-Ala-Pro-Pro-Gln-Pro-Phe-Gly-Pro- Fig. 10 . N-Terminal sequence of basic PRPs PCA, pyrrolidone 5-carboxylic acid. Dlb is peptide P-B described by Isemura et al. (1979) .
contained acidic cystatins when examined by anionic-PAGE/Western transfer. These cystatins exhibited anionic mobility between cystatins SN and S and may be comparable with those cystatin isoforms originally described by Shomers et al. (1982a) as the C2 group of cysteine-containing phosphoproteins. Their relationship to one of the three genetically distinguishable forms of cystatins, cystatin SA (Isemura et al., 1987) , remains to be determined.
Basic PRPs and statherin
The basic PRPs in pool Dl were separated into two components, Dla and Dlb, by Mono S cation-exchange chromatography (Fig. 8b) . Amino acid analysis revealed that Dlb was similar in composition to a basic peptide, P-B, isolated from human whole saliva (Isemura et al., 1979) (Table 5) . NTerminal sequencing indicated that the N-terminus of DIb was blocked, which is consistent with the findings of Isemura et al. (1979) . N-Terminal sequence analysis of Dla revealed that this PRP was a truncated form of peptide P-B which is missing the first seven amino acids (Fig. 10) . These peptides represent a second group of basic PRPs described in HSMSL saliva. Robinson et al. (1989) have described a 44-residue basic PRP from HSMSL saliva which is presumably derived by the proteolytic processing of acidic PRPs. The sequence of this protein is identical with the C-terminal segment (residues 107-150) of human parotid PRPI, PRP2 and PIF-S (Wong & Bennick, 1980; Schlesinger & Hay, 1986; Hay et al., 1988) and identical with a basic PRP isolated from human parotid saliva by Isemura et al. (1980) . Thus it appears that some of the basic PRPs of HSMSL saliva may be derived by proteolytic processing, presumably before their exit from the salivary ducts.
The amino acid composition and the first 30 residues of the Nterminal sequence of pool D2 were identical with that reported for statherin (Schlesinger & Hay, 1977) . When this statherin pool was subjected to Mono Q anion-exchange chromatography, it was found to be comprised of two components, designated D2a and D2b, which were eluted at 0.15 and 0.18 M-NaCl respectively [Fig. 8(c) ; see inset for anionic-PAGE of these materials]. The amino acid profiles of D2a and D2b were comparable (Table 5) and the sequences of their N-terminal 35 residues were identical.
Analysis of alkaline phosphatase-treated D2 by f.p.l.c. indicated that the dephosphorylated statherins now had anionic mobilities that were less than the intact components (Fig. 8c) . These data indicated that the charge variation, as deduced from closely migrating but distinct peaks on f.p.l.c. (Fig. 8c) , was not due to differences in phosphate content. It is likely that the variation between these two statherin isoforms may be due to differences in their C-terminal sequences. Indeed, a study by Jensen et al. (1991) has identified an isoform of statherin which lacks the Cterminal phenylalanine residue.
In summary, we have described an integrated protocol for the efficient purification of the mucins and major phosphoproteins from HSMSL saliva. In general, this protocol was derived from procedures used by several different laboratories for the purification of individual salivary components. It uses an initial step of gel filtration under dissociating conditions which minimizes heterotypic complexing among molecules. Final purification was achieved by conventional ion-exchange chromatography and/or f.p.l.c. As part of this protocol, we report that the smaller human salivary mucin, MG2, exhibits microheterogeneity in its oligosaccharide chains. Two isoforms have been identified which differ primarily in their content of the terminal sugars, sialic acid and fucose. We also report that acidic salivary cystatins can show various degrees of phosphorylation. The first phosphorylation site appears to be serine at position 3. Further work is required to locate definitely the other sites of phosphorylation. Two isoforms of a basic PRP have been purified; one of these represents a truncated form of a previously described basic PRP which is probably derived by proteolytic processing. In general, the multiple isoforms described in this study appear to be the result of post-translational modifications in glycosylation, phosphorylation and proteolytic processing.
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